dc.contributor.author |
Gladâş, Valentina |
|
dc.contributor.author |
Corcimaru, Ion |
|
dc.contributor.author |
Robu, Maria |
|
dc.contributor.author |
Chelea, Iurii |
|
dc.contributor.author |
Musteaţă, Vasile |
|
dc.contributor.author |
Mocanu, Irina |
|
dc.date.accessioned |
2019-06-22T13:13:33Z |
|
dc.date.available |
2019-06-22T13:13:33Z |
|
dc.date.issued |
2011 |
|
dc.identifier.citation |
GLADAS, Valentina, CORCIMARU, Ion et al. Recidivele leucemiei acute promielocitare. In: Anale ştiinţifice ale USMF “Nicolae Testemiţanu”. Ed. a 12-a. Chişinau: СEP Medicina, 2011, vol. 3: Probleme actuale în medicina internă, pp. 347-351. |
en_US |
dc.identifier.uri |
http://repository.usmf.md/handle/20.500.12710/1870 |
|
dc.description |
Catedra Hematologie şi Oncologie a USMF “N.Testemiţanu”
Instituţie Medico-Sanitară Publică Institutul de Oncologie din Moldova |
en_US |
dc.description.abstract |
We have followed up 67 patients with acute promyelocytic leukemia, who underwent
combined treatment with ATRA and polychemotherapy (PCT). Complete remissions were
achieved in 55 (82,1%) cases. Early relapses were registered in 9 (34,6%) patients. Late relapses
developed in 17 ( 66.4%) cases, four of these patients abolished the treatment. Relapses more
often (82,4%) develop in the patients in first 3 years of complete remision, but in following
years the frecvency of relapses is significantly reduced.Repeated combined treatment with
ATRA and PCT appeared to be efficient in 5 (23,8%) cases.
Key words: Acute promyelocytic leukemia, All-trans-retinoic acid, relapse.
Sub supraveghere s-au aflat 67 de bolnavi de leucemie acută promielocitară, care au
primit tratament cu ATRA în combinaţie cu polichimioterapie. Remisiuni complete au fost
obţinute la 55 (82,1%) bolnavi. Recidive precoce au fost constatate la 9 (34,6%) pacienţi,
recidive tardive în 17 (66,4%) cazuri. Recidivele mai frecvent (82,4%) au aparut în primii 3 ani
de remisiune completă, ulterior cu scăderea lor considerabilă. Remisiune completă în
tratamentul recidivelor a fost obţinută la 5 (23,8%) bolnavi. |
en_US |
dc.language.iso |
ro |
en_US |
dc.publisher |
CEP Medicina |
en_US |
dc.subject.mesh |
Acute Promyelocytic Leukaemia |
en_US |
dc.subject.mesh |
Tretinoin |
en_US |
dc.subject.mesh |
Recurrence |
en_US |
dc.title |
Recidivele leucemiei acute promielocitare |
en_US |
dc.title.alternative |
Relapses of acute promyelocitic leukemia |
en_US |
dc.type |
Article |
en_US |